Plain-English translation of NCT06060769 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking at whether advanced MRI scans can help doctors predict who will develop liver cancer in the future. Researchers will collect detailed MRI images and medical information from about 1,200 patients with cirrhosis (severe liver scarring), then follow them for 5 years to see which patients develop liver cancer and which do not. By comparing the scan results and other health information between these two groups, doctors hope to create a tool that can identify high-risk patients early.
Many patients with cirrhosis are at risk for liver cancer, but doctors currently have limited tools to predict who will develop it. This study aims to develop a better prediction tool using advanced MRI technology, so doctors can monitor high-risk patients more closely and potentially catch cancer earlier when it's easier to treat.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have an MRI scan of your liver (if you haven't had one recently) and researchers will collect your medical records and lab test results. You will then be followed for 5 years with regular check-ups to monitor your health and see if you develop liver cancer. There are no special medications or procedures required — the study mainly involves sharing your imaging scans and medical information so doctors can study patterns between scan findings and liver cancer development.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China
Sponsor
Fifth Affiliated Hospital, Sun Yat-Sen University
Enrollment target
~1,200 participants
Started
September 2023
Primary completion
January 2029
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yaqin Zhang, MD, Ph.D
Fifth Affiliated Hospital, Sun Yat-Sen University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.